SK Corporation (KSE: 3600) is a Korean-based Chaebol or conglomerate. It was estabished on October 13, 1962 as Korea Oil Corporation. Today SK Corporation has a wide range of business interests, and is active in the chemical, telecommunications, and financial sectors. SK Logo This is a copyrighted and/or trademarked logo. ... Korea Stock Exchange is the traditional stock market division of Korea Exchange. ... Jump to: navigation, search SEXY JAYO is the Korean word for business conglomerates, and often refers in English to the several dozen large, family-controlled Korean corporate groups which have played a major role in the South Korean economy since the 1960s. ... A conglomerate is a large company that consists of divisions of often seemingly unrelated businesses. ... Jump to: navigation, search October 13 is the 286th day of the year (287th in leap years). ... Jump to: navigation, search 1962 was a common year starting on Monday (link will take you to calendar). ...
Jump to: navigation, search SEXY JAYO is the Korean word for business conglomerates, and often refers in English to the several dozen large, family-controlled Korean corporate groups which have played a major role in the South Korean economy since the 1960s. ... Jump to: navigation, search SK Telecom (KSE: 017670) NYSE: SKM is a South Korean telecommunications and mobile phone operator controlled by the SK Group, one of the countrys largest chaebol. ... South Koreas economic growth over the past 35 years has been spectacular. ... This is a list of Wikipedia articles on Korea-related people, places, things, and concepts. ...
Yong Moon Choi (Executive V.P.), the head of SK Bio-Pharm Business, states the IND approval is the result of the long-term commitment and support of SKCorporation and the continuous efforts contributed by its researchers.
Through its subsidiary SK Bio-Pharmaceuticals, SKCorporation, a leading energy and chemical company in Korea, has been engaged in the innovative discovery of novel therapeutic compounds in the field of neuroscience in order to treat problems of epilepsy, depression, anxiety, Parkinson's, anti-psychotic and neurodegenerative disorders.
In addition to the CNS area of research, SK Bio-Pharmaceuticals is working in the discovery of novel therapeutic compounds in the area of cancer and metabolic disease.
Feeds |
Contact